Clover Biopharmaceuticals, Ltd. (02197)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Ambrosino Donna Marie | 17-Jun-22 | NED | |||
| Chau Anita Hing Ling | 22-Dec-21 | CoSec | |||
| Clemens Ralf Leo | 17-Jun-22 | 19-Jun-25 | NED | Dr. Clemens did not stand for re-election at the Annual General Meeting due to his need to allocate more time to family and personal affairs. He has confirmed that he has no disagreement with the Board and there are no matters with respect to his retirement that need to be brought to the attention of the Stock Exchange or the Shareholders. | |
| Farrow Jeffrey | 26-Sep-21 | INED | |||
| Fung Po Ting | 19-Apr-21 | 22-Dec-21 | CoSec | ||
| Krex Brian | 19-Apr-21 | 31-Mar-23 | CoSec | ||
| 31-Mar-23 | J-CoSec | Due to his other work commitments | |||
| Leggett Thomas | 26-Sep-21 | INED | |||
| Liang Joshua G | 25-Dec-20 | CEO | |||
| Liang Peng | 31-Oct-18 | Ch, Fdr | |||
| Liao Xiang | 26-Sep-21 | INED | |||
| Lyu Dong | 16-Mar-21 | 28-Oct-22 | NED | To focus on other business priorities | |
| 28-Oct-22 | MbAC | To focus on other business priorities | |||
| Wang Xiaodong | 16-Mar-21 | NED | |||
| Wang Xiaoyan | 31-Mar-23 | CoSec | |||
| Wu Xiaobin | 26-Sep-21 | INED | |||
| Xiao Ting | 16-Mar-21 | 22-Apr-22 | NED | To focus on other business priorities | |
| 22-Apr-22 | MbAC | To focus on other business priorities |